Hantz Financial Services’s Teladoc Health TDOC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$0 Hold
10
﹤0.01% 2634
2026
Q1
$0 Sell
10
-8
-44% -$45 ﹤0.01% 2602
2025
Q4
$0 Hold
18
﹤0.01% 2532
2025
Q3
$0 Sell
18
-19
-51% -$148 ﹤0.01% 2442
2025
Q2
$0 Hold
37
﹤0.01% 2297
2025
Q1
$0 Sell
37
-3
-8% -$30 ﹤0.01% 1963
2024
Q4
$0 Hold
40
﹤0.01% 1203
2024
Q3
$0 Sell
40
-2
-5% -$17 ﹤0.01% 1179
2024
Q2
$0 Sell
42
-232
-85% -$2.83K ﹤0.01% 1258
2024
Q1
$4K Buy
274
+125
+84% +$2.27K ﹤0.01% 982
2023
Q4
$3K Sell
149
-2
-1% -$37 ﹤0.01% 1000
2023
Q3
$3K Hold
151
﹤0.01% 990
2023
Q2
$4K Hold
151
﹤0.01% 925
2023
Q1
$4K Buy
151
+2
+1% +$54 ﹤0.01% 934
2022
Q4
$4K Sell
149
-15
-9% -$404 ﹤0.01% 907
2022
Q3
$4K Buy
164
+15
+10% +$526 ﹤0.01% 890
2022
Q2
$5K Sell
149
-25
-14% -$1.06K ﹤0.01% 854
2022
Q1
$13K Buy
+174
New +$12.5K ﹤0.01% 757

Other funds holding TDOC

Hantz Financial Services's TDOC Position: Q2 2026 in Review

Hantz Financial Services held its Teladoc Health (TDOC) position steady in Q2 2026 at 10 shares worth $0. The position accounts for ﹤0.01% of the portfolio, ranked #2634.

Hantz Financial Services first reported a position in TDOC in Q1 2022 and has held it in 18 quarters since. The position peaked at $13K in Q1 2022. 348 funds tracked by Wall St. Rank hold TDOC as of Q2 2026.

  • Hantz Financial Services held 10 shares of Teladoc Health worth $0 as of Q2 2026.
  • Hantz Financial Services left its Teladoc Health share count unchanged in Q2 2026.
  • Teladoc Health made up ﹤0.01% of Hantz Financial Services's portfolio in Q2 2026, its #2634 holding.
  • Hantz Financial Services first reported a position in Teladoc Health in Q1 2022 and has held it in 18 quarters since.
  • Hantz Financial Services's Teladoc Health position peaked at $13K in Q1 2022.
  • 348 funds tracked by Wall St. Rank held Teladoc Health as of Q2 2026.

Based on Hantz Financial Services's 13F filing for Q2 2026, filed 13 Aug 2026.